Cerus reported $-1.45M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Cerus USD -1.45M 488K Dec/2024
GRIFOLS EUR 249M 103.11M Mar/2026
Haemonetics USD 67.4M 13.71M Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Quidel USD -27.4M 9.9M Mar/2026
STAAR Surgical USD 17.4M 28.34M Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Utah Medical Products USD 2.44M 2M Dec/2025